Header cover image

Hong Kong Pharmaceuticals & Biotech Top Growth Stocks

Results

7

0 new
According to our Simply Wall St analysis these are the best growth companies.. We look for companies with high forecasted growth and healthy balance sheets that can deliver sustained growth over the long term.

7 companies

Cutia Therapeutics

Market Cap: HK$1.3b

An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.

2487

HK$3.59

7D

-13.7%

1Y

-62.9%

Ocumension Therapeutics

Market Cap: HK$5.1b

Engages in the research, discovery, development, and commercialization of ophthalmic therapies in China.

1477

HK$6.20

7D

-0.6%

1Y

-19.1%

Everest Medicines

Market Cap: HK$10.6b

A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.

1952

HK$30.14

7D

-5.2%

1Y

-31.7%

CanSino Biologics

Market Cap: HK$11.2b

Develops, manufactures, and commercializes vaccines in the People’s Republic of China.

6185

HK$25.82

7D

-8.0%

1Y

-23.6%

InSilico Medicine Cayman TopCo

Market Cap: HK$23.8b

Engages in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms.

3696

HK$41.58

7D

-17.5%

1Y

n/a

GenFleet Therapeutics (Shanghai)

Market Cap: HK$12.6b

A biopharmaceutical company, develops treatment options in the fields of oncology, autoimmune, and inflammatory diseases in the United States.

2595

HK$34.12

7D

1.9%

1Y

n/a

WuXi XDC Cayman

Market Cap: HK$69.2b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

2268

HK$54.90

7D

-4.2%

1Y

37.4%